Why Sonnet BioTherapeutics Shares Are Trading Lower By Around 13%; Here Are 20 Stocks Moving Premarket

Gainers

• Clearmind Medicine Inc. CMND jumped 69.3% to $0.8480 in pre-market trading after dropping 12% on Tuesday. Clearmind Medicine recently announced a $3.5 million public offering priced at $0.78 per share.
• a.k.a. Brands Holding Corp. AKA gained 32.6% to $0.5393 in pre-market trading after the company announced preliminary unaudited Q1 2023 results. The company sees Q1 net sales of $120 million, versus previous estimate of $113 million to $116 million.
• Getaround, Inc. GETR surged 26.1% to $0.3216 in pre-market trading. Getaround recently said it sees preliminary FY22 total revenues of $59 million to $60 million.
• Bed Bath & Beyond Inc. BBBY shares climbed 24.8% to $0.4282 in pre-market trading after jumping 22% on Tuesday. Bed Bath & Beyond recently filed preliminary prospectus for resale of up to 111.7 million shares of common stock by B. Riley Principal Capital II.
• Intuitive Machines, Inc. LUNR climbed 24.8% to $12.98 in pre-market trading. Intuitive Machines said The National Aeronautics and Space Administration awarded Space & Technology Solutions, the DBA for Space Networks Solutions LLC, a joint venture led by Intuitive Machines with KBR, a cost-plus-fixed-fee indefinite-delivery, indefinite-quantity contract meant to support work related to the Joint Polar Satellite System, NASA’s Exploration and In-space Services.
• China Jo-Jo Drugstores, Inc. CJJD gained 17.3% to $0.7910 in pre-market trading. China Jo-Jo Drugstores shares dropped over 85% on Tuesday after the company announced a $7 million registered direct offering.
• Western Alliance Bancorporation WAL gained 15.4% to $37.50 in pre-market trading after the company reported better-than-expected Q1 earnings.
• Genprex, Inc. GNPX gained 14.7% to $1.09 in pre-market trading after gaining 3% on Tuesday.
• Metropolitan Bank Holding Corp. MCB climbed 14.6% to $35.31 in pre-market trading following better-than-expected Q1 earnings.
• SenesTech, Inc. SNES gained 14.2% to $1.77 in pre-market trading after gaining 21% on Tuesday. HC Wainwright & Co. reiterated SenesTech with a Buy and maintained a $4 price target.

Losers

• Oblong, Inc. OBLG fell 22% to $2.69 in pre-market trading after jumping more than 61% on Tuesday.
• Super League Gaming, Inc. SLGG shares dropped 21% to $0.5224 in pre-market trading. Super League Gaming shares jumped over 54% on Tuesday after the company and LandVault announced a strategic partnership to provide brands with scalable solutions to bridge the gap between Web2 and Web3.
• FOXO Technologies Inc. FOXO fell 18.4% to $0.6230 in pre-market after dropping 8% on Tuesday. FOXO Technologies announced resignation of Taylor Fay, Chief Operating Officer, effective April 28, 2023.
• Gamida Cell Ltd. GMDA fell 18.3% to $1.38 in pre-market trading. Gamida Cell shares jumped over 50% on Tuesday after the company announced it received FDA approval for Omisirge allogeneic cell therapy.
• Panbela Therapeutics, Inc. PBLA fell 14.2% to $0.5327 in pre-market trading after gaining around 14% on Tuesday. Panbela Therapeutics recently announced the first patient has been enrolled in the Phase II trial of CPP-1X-T.
• Biocept, Inc. BIOC fell 14.1% to $0.3010 in pre-market trading. Biocept recently reported 2022 loss of $1.89 per share.
• SAB Biotherapeutics, Inc. SABS fell 13.4% to $0.94 in pre-market trading. SAB Therapeutics shares gained around 42% on Tuesday after the company announced the FDA has granted Breakthrough Therapy Designation to SAB-176.
• United Insurance Holdings Corp. UIHC shares fell 12.8% to $1.57 in pre-market trading after dipping over 48% on Tuesday.
• Sonnet BioTherapeutics Holdings, Inc. SONN fell 12.7% to $0.2910 in pre-market trading after the company announced updated clinical data for SON-1010 at the 2023 American Association for Cancer Research Annual Meeting.
• Windtree Therapeutics, Inc. WINT fell 11.7% to $5.88 in pre-market trading after dropping over 19% on Tuesday. Windtree Therapeutics recently announced the European Patent Office has granted Patent No. 3599243, providing patent coverage for the dual mechanism SERCA2a Activator class of drug candidates.

Now Read This: Top 5 Industrials Stocks You May Want To Dump This Quarter